Literature DB >> 9563080

Pulsatile drug release from an insoluble capsule body controlled by an erodible plug.

I Krögel1, R Bodmeier.   

Abstract

PURPOSE: The objective of this study was to develop and evaluate a pulsatile drug delivery system based on an impermeable capsule body filled with drug and an erodible plug placed in the opening of the capsule body.
METHODS: The erodible plugs were either prepared by direct compression followed by placing the tablets in the capsule opening or by congealing a meltable plug material directly within the capsule opening. The disintegration/erosion properties of these plugs were determined and optimized for the final delivery system. In order to assure rapid drug release of the capsule content after erosion of the plug, various excipients (fillers, effervescent agents) and drugs with different solubilities were evaluated. The lag time prior to drug release and the subsequent drug release were investigated as function of capsule content, plug composition, plug preparation technique, plug hardness, weight, and thickness.
RESULTS: The erosion time of the compressed plugs increased with increasing molecular weight of the hydrophilic polymer (e.g. hydroxypropyl methylcellulose, polyethylene oxide), decreasing filler (lactose) content and decreased with congealable lipidic plugs with increasing HLB-value and inclusion on surfactants. For complete and rapid release of the drug from the capsule body, effervescent agents had to be included in the capsule content. The drug delivery system showed typical pulsatile release profiles with a lag time followed by a rapid release phase. The lag time prior to the pulsatile drug release correlated well with the erosion properties of the plugs and, besides the composition of the plug, could be controlled by the thickness (weight) of the plug.
CONCLUSIONS: A single-unit, capsular-shaped pulsatile drug delivery system was developed wherein the pulsatile release was controlled by the erosion properties of a compressed or congealed plug placed within the opening of the capsule opening.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563080     DOI: 10.1023/a:1011940718534

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Relationship between polymer viscosity and drug release from a matrix system.

Authors:  L W Cheong; P W Heng; L F Wong
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.

Authors:  R Bodmeier; O Paeratakul
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

3.  Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.

Authors:  I R Wilding; S S Davis; M Bakhshaee; H N Stevens; R A Sparrow; J Brennan
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

4.  The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

5.  Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.

Authors:  S Ueda; T Hata; S Asakura; H Yamaguchi; M Kotani; Y Ueda
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

  5 in total
  4 in total

1.  Evaluation of an enzyme-containing capsular shaped pulsatile drug delivery system.

Authors:  I Krögel; R Bodmeier
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 2.  Colon-targeted oral drug delivery systems: design trends and approaches.

Authors:  Seth Amidon; Jack E Brown; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

3.  Pulsatile release of parathyroid hormone from an implantable delivery system.

Authors:  Xiaohua Liu; Glenda J Pettway; Laurie K McCauley; Peter X Ma
Journal:  Biomaterials       Date:  2007-06-18       Impact factor: 12.479

4.  Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate.

Authors:  Jaber Emami; Mohammad-Reza Kazemali
Journal:  Res Pharm Sci       Date:  2016 Jan-Feb
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.